August 31, 2016 3:53 AM ET

Biotechnology

Company Overview of Emergent BioSolutions, Inc.

Executive Profile

Zsolt P. Harsanyi Ph.D.

Non Executive Director, Chairman of Audit Committee, Member of Scientific Review Committee and Member of Strategic Operations Committee, Emergent BioSolutions, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 5 different industries.

See Board Relationships
72$398,966

Background

Dr. Zsolt P. Harsanyi, Ph.D. served as Chief Executive Officer of Exponential Biotherapies, Inc. from December 2004 to February 2011. Dr. Harsanyi served as President of Porton International plc from January 1983 to December 2004. he served as Vice President of Corporate Finance at E.F. Hutton, Inc. with responsibility for assessing and financing biotechnology companies. Dr. Harsanyi founded Dynport Vaccine Company LLC in September 1996. From 1979 to 1981, Dr. Harsanyi ...

Corporate Headquarters

400 Professional Drive
Gaithersburg, Maryland 20879

United States

Phone: 240-631-3200
Fax: 240-631-3203

Board Members Memberships

Chairman
Director
Director and Chairman of Audit Committee
2004-Present
Non Executive Director, Chairman of Audit Committee, Member of Scientific Review Committee and Member of Strategic Operations Committee

Education

BA 1965
Amherst College
PhD 1970
Albert Einstein College of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$103,900
Total Calculated Compensation$398,966
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Schoeneck Chief Executive Officer, President and Director
Depomed, Inc.
$708.3K
William S. Marth Chief Executive Officer, President and Director
Albany Molecular Research Inc.
$650.0K
Kimberly J. Popovits Chairman of The Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$686.4K
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
$9.3M
John N. Kapoor Ph.D.Executive Chairman, Chief Executive Officer and President
INSYS Therapeutics, Inc.
$53.3K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Emergent BioSolutions, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.